Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycobiology of Neuroblastoma: Impact on Tumor Behavior, Prognosis, and Therapeutic Strategies
Nora Berois, Eduardo Osinaga
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha, Cengiz Inal, Taofeek K. Owonikoko
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 219
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 77
GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
Sharareh Gholamin, Hamed Mirzaei, Seyed‐Mostafa Razavi, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 2, pp. 866-879
Closed Access | Times Cited: 104
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton, et al.
Nature Cancer (2022) Vol. 3, Iss. 8, pp. 976-993
Open Access | Times Cited: 61
GD2-targeting therapy: a comparative analysis of approaches and promising directions
Julia Philippova, Julia Shevchenko, С. В. Сенников
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes
Jahanshah Ashkani, Kevin J. Naidoo
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 79
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Helen Blanchard, Khuchtumur Bum‐Erdene, M.H. Bohari, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 5, pp. 537-554
Closed Access | Times Cited: 77
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
Michelle E. Keyel, C. Patrick Reynolds
Biologics (2018) Vol. Volume 13, pp. 1-12
Open Access | Times Cited: 66
Cell death-based treatment of neuroblastoma
Kadri Valter, Boris Zhivotovsky, Vladimir Gogvadze
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 41
Role of Immunotherapy in Sarcomas
Shivani Dalal, Khine Shan, Nyein Nyein Thaw Dar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1266-1266
Open Access | Times Cited: 4
Gangliosides and Neuroblastomas
Cara‐Lynne Schengrund
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5313-5313
Open Access | Times Cited: 32
N-Linked Glycan Profiling in Neuroblastoma Cell Lines
Yunli Hu, Anoop Mayampurath, Saira Khan, et al.
Journal of Proteome Research (2015) Vol. 14, Iss. 5, pp. 2074-2081
Open Access | Times Cited: 27
Mass spectrometry of gangliosides in extracranial tumors: Application to adrenal neuroblastoma
Adrian Robu, Z̆eljka Vukelić, Catalin Schiopu, et al.
Analytical Biochemistry (2016) Vol. 509, pp. 1-11
Closed Access | Times Cited: 23
Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells
Liang Gong, Xiangdong Zhou, Jingxiang Yang, et al.
Oncology Reports (2016) Vol. 37, Iss. 1, pp. 131-138
Open Access | Times Cited: 23
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy
Araz Marachelian, Ami V. Desai, Frank M. Balis, et al.
Cancer Chemotherapy and Pharmacology (2016) Vol. 77, Iss. 2, pp. 405-412
Open Access | Times Cited: 22
Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA
Connie P.M. Duong, Sakiko Yoshida, Cathy Chen, et al.
Pediatric Research (2017) Vol. 82, Iss. 3, pp. 527-535
Open Access | Times Cited: 19
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease
Nicholas Smith, Maria Fuller, Jennifer T. Saville, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 1, pp. 120-128
Open Access | Times Cited: 19
Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients
Xiaolin Wang, Wenjun Mou, Wei Han, et al.
Clinical Immunology (2019) Vol. 203, pp. 63-71
Closed Access | Times Cited: 19
Comprehensive Profiling of Surface Gangliosides Extracted from Various Cell Lines by LC-MS/MS
Jua Lee, Heeyoun Hwang, Sumin Kim, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1323-1323
Open Access | Times Cited: 19
Lactulose as a novel template for anticancer drug development targeting galectins
Chandan Kishor, Renee L. Ross, Helen Blanchard
Chemical Biology & Drug Design (2018) Vol. 92, Iss. 4, pp. 1801-1808
Closed Access | Times Cited: 15
Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model
Kimberly J. Ornell, Jordan S. Taylor, Jasmine Zeki, et al.
Cancer Medicine (2020) Vol. 9, Iss. 8, pp. 2891-2903
Open Access | Times Cited: 13
Advances in new targets for immunotherapy of small cell lung cancer
Zitong Zheng, Juanjuan Liu, Junling Ma, et al.
Thoracic Cancer (2023) Vol. 15, Iss. 1, pp. 3-14
Open Access | Times Cited: 4
Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors
Arsenij Ustjanzew, Annekathrin Silvia Nedwed, Roger Sandhoff, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Modulation of Endocannabinoid-Binding Receptors in Human Neuroblastoma Cells by Tunicamycin
Cinzia Rapino, Annalisa Castellucci, Anna Rita Lizzi, et al.
Molecules (2019) Vol. 24, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 10
Frequency of ALK and GD2 Expression in Neuroblastoma
Zeynep Aygün, Şebnem Batur, Şenol Emre, et al.
Fetal and Pediatric Pathology (2019) Vol. 38, Iss. 4, pp. 326-334
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top